SI
Silo Pharma, Inc.
SILO · NASDAQ
$2.07 -3.27% (-$0.07)
1M -32.57%
Market Cap $2.34M
P/E Ratio -
Div. Yield -
ROE 81.74%
Piotroski F-Score Weak
1/9Valuation
50 /100
Fair P/B 0.48x
P/S 43.20x
EV/EBITDA N/A
Growth
16 /100
Declining Book val. growth 15.20%
Rev. growth 0.00%
FCF growth N/A
Profitability
0 /100
Weak Net margin 8,269.53%
Op. margin 8,250.46%
FCF margin 6,176.84%
Quality
0 /100
Poor ROE 81.74%
ROA 75.13%
Asset turnover 0.01x
Debt
69 /100
Low Current ratio 5.36x
Int. coverage -115.27x
Debt/Equity 0.00x
Stability
76 /100
Stable Rev. volatility 0.00%
EPS volatility 28.58%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SILO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Eric Weisblum
Employees
3
Headquarters
Sarasota
Prihajajoči dogodki
02 DEC.
Earnings
Upcoming earnings report